Geneva, Aug. 17 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129715) titled 'Sclerosing epithelioid fibrosarcoma with initial presentation as pulmonar... Read More
Geneva, Aug. 17 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129712) titled 'Interpretable quantitative decision making and its mechanism for extrahep... Read More
Geneva, Aug. 17 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129716) titled 'The Effect of Neuromuscular Control Training Exercise Intervention on Low... Read More
Geneva, Aug. 17 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129713) titled 'Vitamin D Deficiency and Postoperative Cognitive Dysfunction' on Aug. 8. ... Read More
Geneva, Aug. 17 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129717) titled 'Evaluation of the Efficacy of Perfluorohexyloctane Eye Drops Combined wit... Read More
Geneva, Aug. 17 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129714) titled 'Research on the mechanism of subthreshold depression emotion regulation a... Read More
Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of ascimi... Read More
Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'A multi-center, open-label, phase I/II study to evaluate the safety and efficacy of asciminib with ... Read More
Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy v... Read More
Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'CA2400030: A Randomized, Phase 2/3 Study Comparing Navlimetostat in Combination with Nab-paclitaxel... Read More